Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Animal blood flow imaging detection is a specialized preclinical and veterinary diagnostic service that visualizes and quantifies hemodynamic parameters such as perfusion, vascular morphology, and flow velocity in living animal models. Using advanced modalities including Doppler ultrasound, laser speckle contrast imaging, fluorescence angiography, and photoacoustic imaging, accredited third-party laboratories and research institutions support drug development, medical device evaluation, and disease mechanism studies. This article provides a comprehensive technical overview of sample types, tested parameters, analytical methods, quality standards, and practical applications of animal blood flow imaging detection.

Technical Overview

Animal blood flow imaging detection refers to the use of non-invasive or minimally invasive imaging technologies to visualize, measure, and longitudinally monitor blood circulation and microvascular function in animal models. These techniques generate quantitative data on hemodynamic parameters such as blood flow velocity, tissue perfusion, vascular diameter, microvessel density, and vascular reactivity, which are essential endpoints in cardiovascular pharmacology, regenerative medicine, oncology, and medical device research.

Modern blood flow imaging platforms combine high spatial resolution with real-time acquisition, enabling both structural angiography and functional perfusion mapping. Depending on the research objective, imaging depth, and required resolution, laboratories may deploy ultrasound-based systems, optical imaging systems, or advanced hybrid modalities. Studies are typically conducted in facilities operating under quality management systems aligned with ISO 13485, with animal welfare procedures consistent with ISO 10993-2 (animal welfare requirements) and applicable GB/T laboratory animal standards, and reporting follows recognized best-practice frameworks such as the ARRIVE guidelines.

Testing Samples

Blood flow imaging detection can be performed across a broad spectrum of animal models, from small laboratory rodents to large translational species. The selection of model depends on the target vascular bed, disease indication, and required translational relevance.

Rodent Models (Mice and Rats)

Rodents are the most widely used models due to their well-characterized genetics, cost efficiency, and availability of disease models. Typical applications include cerebral perfusion mapping in stroke models, hindlimb perfusion in peripheral artery disease and ischemia-reperfusion studies, renal and mesenteric vascular assessment, and tumor vascularization monitoring. High-frequency ultrasound (30–50 MHz) and laser speckle systems are optimized for rodent-scale vessels.

Rabbit Models

Rabbits provide larger-caliber vessels suitable for atherosclerosis research, vascular graft evaluation, and ear-window microcirculation studies. Their vessel dimensions support higher-resolution Doppler measurements and catheter-based interventions.

Canine and Porcine Models

Dogs, and particularly pigs, offer cardiovascular anatomy and hemodynamics closely resembling those of humans. These large-animal models are preferred for coronary flow assessment, stent and vascular implant testing, myocardial perfusion studies, and preclinical validation under ISO 25539-series vascular device requirements.

Zebrafish and Other Small Organism Models

Zebrafish embryos and larvae enable high-throughput, whole-organism angiogenesis screening using optical coherence tomography and fluorescence microscopy, supporting rapid pharmacological evaluation of pro-angiogenic or anti-angiogenic compounds.

Ex Vivo Tissues and Isolated Organs

Perfused organ preparations, vascular casts, and dissected tissues can be evaluated using micro-CT angiography and corrosion casting techniques to obtain three-dimensional vascular architecture data with micrometer-level resolution.

Testing Items

Animal blood flow imaging detection services typically quantify the following parameters:

  • Blood flow velocity: peak systolic velocity, end-diastolic velocity, mean velocity, and pulsatility and resistance indices
  • Tissue perfusion: perfusion units, perfusion rate maps, and regional perfusion ratios in ischemic versus control territories
  • Vascular morphology: vessel diameter, wall thickness, lumen area, tortuosity, and stenosis grading
  • Microvascular density: quantification of microvessel count and vascular area fraction in angiogenesis studies
  • Cardiac hemodynamics: cardiac output, stroke volume, ejection fraction, and aortic flow profiles
  • Ischemia-reperfusion dynamics: temporal perfusion recovery curves and infarct-zone perfusion deficits
  • Thrombosis and flow obstruction: detection of stasis, thrombus burden, and vessel occlusion
  • Vascular reactivity: vasodilator and vasoconstrictor response testing following pharmacological challenge
  • Oxygenation-related parameters: blood oxygen saturation mapping where photoacoustic or multispectral modalities are applied
  • Longitudinal angiogenesis endpoints: serial quantification of neovascularization in wound healing and tissue engineering studies

Testing Methods

Laboratories apply complementary imaging modalities according to the required penetration depth, resolution, and functional endpoints. Equipment performance is verified in accordance with applicable IEC 60601-series safety and performance requirements for diagnostic imaging equipment.

Doppler Ultrasound Imaging

Color Doppler, power Doppler, and pulsed-wave Doppler techniques provide real-time velocity mapping and spectral analysis of named vessels and cardiac chambers. High-frequency linear arrays designed for small animals enable resolution sufficient for mouse arterial studies.

Contrast-Enhanced Ultrasound (CEUS)

Microbubble contrast agents amplify signals from the microcirculation, permitting quantification of tissue perfusion through time-intensity curve analysis and parameters such as peak enhancement, time-to-peak, and area under the curve.

Laser Speckle Contrast Imaging (LSCI)

LSCI delivers wide-field, real-time perfusion maps of superficial vascular beds such as cerebral cortex, skin flaps, and hindlimb muscle, making it ideal for continuous ischemia-reperfusion monitoring without contrast agents.

Laser Doppler Flowmetry and Perfusion Imaging

Point and scanning laser Doppler systems measure microvascular perfusion in defined tissue regions, providing baseline and stimulated flux values expressed in perfusion units.

Fluorescence Angiography

Intravascular fluorescent tracers such as indocyanine green enable dynamic angiographic sequences for assessing vessel patency, perfusion territory, and flap viability, particularly in surgical and transplantation research.

Photoacoustic Imaging

Combining optical contrast with ultrasonic resolution, photoacoustic tomography quantifies total hemoglobin concentration and oxygen saturation in deep tissues, supporting tumor hypoxia and oxygen-metabolism studies.

Micro-CT Angiography

Vascular casting and contrast-enhanced micro-CT produce high-resolution three-dimensional reconstructions of vascular networks for morphometric analysis of branching, density, and remodeling.

MRI-Based Perfusion Imaging

Arterial spin labeling and dynamic contrast-enhanced MRI provide non-ionizing, quantitative perfusion measurement in deep organs, including brain, kidney, and myocardium, supporting longitudinal longitudinal study designs.

Applications

Animal blood flow imaging detection serves as a critical endpoint platform across multiple research and development domains:

  • Cardiovascular and cerebrovascular drug development: efficacy assessment of vasodilators, antithrombotics, anti-inflammatory agents, and pro-angiogenic therapies in validated disease models
  • Peripheral artery disease and ischemia research: quantification of collateral vessel formation and limb perfusion recovery following therapeutic angiogenesis interventions
  • Stroke and neurovascular studies: cerebral blood flow mapping before, during, and after vessel occlusion in focal ischemia models
  • Oncology research: longitudinal monitoring of tumor angiogenesis and vascular-disrupting or anti-angiogenic treatment response
  • Wound healing and regenerative medicine: perfusion tracking in burns, diabetic wounds, scaffolds, and tissue-engineered constructs
  • Medical device evaluation: performance and safety testing of vascular grafts, stents, and implants, with local biological effects assessed in line with ISO 10993-6 and device-specific ASTM and ISO standards
  • Diabetes complication models: microvascular dysfunction quantification in retina, kidney, and peripheral nerve beds
  • Transplantation and reconstructive surgery: graft and flap perfusion assessment, reperfusion injury characterization, and survival prediction
  • Toxicology and safety pharmacology: detection of compound-induced vascular toxicity and hemodynamic adverse effects

FAQ

What is animal blood flow imaging detection?

It is a set of imaging-based testing services that visualize and quantify blood circulation in animal models, generating objective hemodynamic data such as flow velocity, perfusion, and vascular morphology for preclinical research and device evaluation.

Which imaging modality should be selected for my study?

Modality selection depends on target tissue depth and desired endpoints. LSCI and fluorescence angiography suit superficial and real-time perfusion studies, Doppler and CEUS suit deep vessels and cardiac assessment, and photoacoustic or MRI methods suit oxygenation and deep-organ perfusion quantification. Study designers at accredited third-party laboratories can recommend an optimized protocol.

Is the procedure non-invasive, and can animals be monitored longitudinally?

Most modalities, including ultrasound, LSCI, photoacoustic imaging, and MRI, are non-invasive and support repeated measurements in the same animal, which reduces animal numbers and improves statistical power while aligning with the 3Rs principles.

How are animals prepared for imaging?

Animals are typically anesthetized with agents selected to minimize cardiovascular depression, maintained at controlled body temperature, and positioned to expose the region of interest. Hair removal over the imaging window is required for optical and ultrasound acquisitions. All procedures are reviewed by institutional animal care and ethics committees.

What standards and guidelines apply to this testing?

Facility operations commonly reference ISO 13485 quality management, ISO 10993-2 animal welfare requirements, relevant GB/T laboratory animal standards, IEC 60601-series equipment requirements, and ARRIVE reporting guidelines for animal studies.

What deliverables are provided after testing?

Standard deliverables include annotated images and cine loops, quantitative flow and perfusion datasets, statistical comparisons between groups, time-course curves for longitudinal studies, and a comprehensive analytical report with methodology and equipment specifications.

How long does a typical blood flow imaging study take?

Single-session imaging can often be completed within one hour per animal, including anesthesia and preparation. Full longitudinal studies spanning baseline, intervention, and follow-up time points typically range from several days to several weeks depending on the disease model and therapeutic window.